Position in BMY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,341
-$176 QoQ
Shares Held
58
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,465
of 2,506 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MRP Capital Investments, LLC holds $6,725,014 across 7 Drug Manufacturers - General names. BMY ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,932 | $3,516,728 | |
| 2 | JNJ |
Johnson & Johnson
|
6,201 | $1,574,867 | |
| 3 | PFE |
Pfizer Inc
|
47,847 | $1,152,155 | |
| 4 | AMGN |
Amgen Inc
|
650 | $235,378 | |
| 5 | ABBV |
AbbVie Inc.
|
512 | $128,839 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
900 | $113,706 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
58 | $3,341 |
All Filings in BMY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,341 | 58 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,517 | 58 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,128 | 58 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $187,525 | 4,158 | Shares | Sole | 2025-12-08 | |
| 2025-06-30 | $192,473 | 4,158 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $616,486 | 10,108 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $529,288 | 9,358 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,000 | 58 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $3,709 | 58 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $17,951 | 259 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,173 | 58 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||